Correspondence re: C.V. Rao, et al., Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced lymphoma formation by oltipraz. Cancer Res., 56: 3395-3398, 1996.
Roebuck
B D
BD
Rogers
A E
AE
Kensler
T W
TW
D016604:Aflatoxin B1; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D019337:Hematologic Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D007093:Imidazoles; D008223:Lymphoma / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats; D011916:Rats, Inbred F344; D013871:Thiones; D013876:Thiophenes
D016588:Anticarcinogenic Agents; D007093:Imidazoles; D011719:Pyrazines; D013871:Thiones; D013876:Thiophenes; C026209:oltipraz; C049584:2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine; D016604:Aflatoxin B1